Nasdaq-listed Artelo Biosciences Completes $11 Million Private Placement Financing

GateNews

2026-03-29 04:30:27

SOL-2,39%

Gate News reported that on March 29, Nasdaq-listed Solana treasury company Artelo Biosciences announced the completion of a private placement, selling a total of 3,188,407 shares of common stock at a price of $3.45 per share, raising a total of $11 million. The company stated that the new funds will be used for general corporate purposes and to repay part of its transitional debt. According to the latest data from StrategicSolanaReserve, Artelo currently holds 45,883 SOL.

View Source

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.

Comment

0/400

No comments